NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $105,226 | -90.3% | 66,180 | -94.8% | 0.00% | – |
Q4 2023 | $1,084,397 | +380.0% | 1,262,395 | +497.9% | 0.00% | – |
Q3 2023 | $225,902 | -24.6% | 211,123 | +82.6% | 0.00% | – |
Q2 2023 | $299,414 | +10968.9% | 115,604 | -82.6% | 0.00% | -100.0% |
Q1 2023 | $2,705 | +17.6% | 662,966 | +44.7% | 0.00% | +100.0% |
Q4 2022 | $2,300 | -99.9% | 458,230 | +98.5% | 0.00% | -50.0% |
Q3 2022 | $3,019,000 | -46.7% | 230,846 | -47.7% | 0.00% | -50.0% |
Q2 2022 | $5,660,000 | -11.1% | 441,475 | +5.8% | 0.00% | +33.3% |
Q1 2022 | $6,366,000 | -32.7% | 417,416 | -21.9% | 0.00% | -40.0% |
Q4 2021 | $9,463,000 | +53.4% | 534,349 | +82.1% | 0.01% | +66.7% |
Q3 2021 | $6,168,000 | +654.0% | 293,442 | +607.1% | 0.00% | – |
Q2 2021 | $818,000 | +87.6% | 41,501 | +176.7% | 0.00% | – |
Q1 2021 | $436,000 | -69.5% | 15,000 | -83.3% | 0.00% | -100.0% |
Q3 2020 | $1,429,000 | +518.6% | 89,803 | +667.4% | 0.00% | – |
Q2 2020 | $231,000 | -80.3% | 11,703 | -87.7% | 0.00% | -100.0% |
Q1 2020 | $1,172,000 | -7.4% | 95,082 | +38.9% | 0.00% | +50.0% |
Q4 2019 | $1,265,000 | +538.9% | 68,435 | +377.7% | 0.00% | – |
Q3 2019 | $198,000 | -72.4% | 14,327 | -70.8% | 0.00% | -100.0% |
Q2 2019 | $718,000 | – | 49,016 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |